HAS Healthcare Advanced Synthesis, is a CDMO with four decades of international experience; the company offers a full range of customized services, from development to production. HAS Healthcare Advanced Synthesis SA develops and manufactures active pharmaceutical ingredients (APIs), highly potent active pharmaceutical ingredients (HPAPIs) and anticancer compounds.

The production site, founded in 1984, is located in Biasca, Switzerland. SwissMedic, the FDA, and other global regulatory agencies regularly inspect the facility. HAS operates dedicated production plants with capacities ranging from a few hundred grams to tens of kilograms for highly potent active ingredients (HPAPIs) and anticancer compounds and from kilograms to tens of tons for standard active ingredients (APIs); the plants are fully dedicated to cGMP production.